MacroLensNP नेपालीने Sign in Create accountSign up
Free · Hydropower

MEN Mountain Energy Nepal Limited

Rs 567.00 +2.00 (+0.35%) as of 2026-11-06 15:00:00
Open
566.10
High
571.00
Low
565.00
Prev. close
565.00
Volume
50,914
Turnover
2.89 crore
Avg volume (30 d)
127,091
52-week low Rs 535.00
high Rs 683.40 -17.0% from the 52-week high

Mountain Energy Nepal Limited (MEN) is listed on the Nepal Stock Exchange in the Hydropower sector. Its share price is Rs 567.00 as of 6 November 2026, 17.0% below its 52-week high of Rs 683.40 and 6.0% above its 52-week low of Rs 535.00. It trades at a P/E of 22.2 on earnings per share of Rs 25.52, cheaper than the Hydropower sector's median P/E of 50.9.

MEN paid a dividend in 5 of the last 5 fiscal years we track; the latest was 1.05% cash for FY 2082/2083.

Key figures latest report 2082/2083 Q4

Market value
2,125 crore · 21.25 arba
Shares listed
31,232,589
Paid-up capital
312.33 crore · 3.12 arba
EPS (annualised)
Rs 25.52
P/E
22.2
Book value / share
Rs 150.78
P/B
3.76
ROE
16.9%
ROA
11.39%
Dividend yield
0.19%
Net profit (annualised)
79.70 crore
Reserves
158.59 crore · 1.59 arba
Total assets
699.85 crore · 7.00 arba
Debt to equity
–

Quarter by quarter trailing 12 months at each quarter

QuarterEPSEPS growth (y/y)Net profitRevenueROE
2082/2083 Q4 21.27 +5.6% 79.70 crore 153.35 crore · 1.53 arba 18.2%
2082/2083 Q3 22.15 +92.3% 69.17 crore 146.92 crore · 1.47 arba 16.5%
2082/2083 Q2 21.08 +80.1% 65.85 crore 142.86 crore · 1.43 arba 16.1%
2082/2083 Q1 23.92 +204.4% 74.72 crore 145.89 crore · 1.46 arba 19.1%
2081/2082 Q4 20.14 +208.9% 62.91 crore 131.37 crore · 1.31 arba 17.0%
2081/2082 Q3 11.51 -20.4% 35.96 crore 103.92 crore · 1.04 arba 10.0%
2081/2082 Q2 11.71 -8.6% 36.57 crore 104.94 crore · 1.05 arba 10.4%
2081/2082 Q1 7.86 -37.7% 24.55 crore 102.77 crore · 1.03 arba 7.1%

Dividends

Fiscal yearBonusCashBook close
2082/2083– 1.05% –
2081/208220.00% 1.05% 3 Dec 2025
2080/208115.00% 0.79% 26 Dec 2024
2079/208015.00% 0.79% 13 Mar 2024
2078/2079– 10.53% 13 Dec 2022

Bonus / right shares: Dec 2025 Bonus share 20% · Dec 2024 Bonus share 15% · Mar 2024 Bonus share 15%

Who owns it

Promoters 0% Public 100%
Public float
37,479,106 shares
Mutual funds hold
5.7% of the float
Promoter lock-in
ended 3 Dec 2023

MacroLens analysis of MEN

More on MEN on the full desk The rating and verdict, fair value, dump risk and warning signs, the 12-month target, the buy / sell meter with every past signal, cornering and broker activity - the analysis behind every number above. Create an account - 7-day trial

Other Hydropower companies

CompanyPriceTodayP/EP/BMarket value
SOHL Solu Hydropower Limited 628.00 +0.05% 56.44.55 6,280 crore · 62.80 arba
UPPER Upper Tamakoshi Hydropower Ltd 194.00 +0.52% 44.44.36 4,109 crore · 41.09 arba
SAHAS Sahas Urja Limited 722.00 +0.98% 24.34.00 3,302 crore · 33.02 arba
CHCL Chilime Hydropower Company Lim... 338.00 +0.06% 44.52.73 3,206 crore · 32.06 arba
BPCL Butwal Power Company Limited 694.00 -1.70% 70.53.29 2,366 crore · 23.66 arba
API Api Power Company Ltd. 333.70 +0.21% 22.22.79 2,129 crore · 21.29 arba
SHPC Sanima Mai Hydropower Ltd. 558.30 +0.96% 71.14.06 2,087 crore · 20.87 arba
TAMOR Sanima Middle Tamor Hydropower... 599.00 +0.67% 32.04.65 1,996 crore · 19.96 arba

Every Hydropower company 112

Browse all NEPSE stocks by sector →

MEN: common questions

What is the share price of MEN today?

MEN (Mountain Energy Nepal Limited) closed at Rs 567.00 as of 6 November 2026 on NEPSE.

Does MEN pay dividends?

MEN paid a dividend in 5 of the last 5 fiscal years we track; the latest was 1.05% cash for FY 2082/2083.

What is the P/E ratio of MEN?

It trades at a P/E of 22.2 on earnings per share of Rs 25.52, cheaper than the Hydropower sector's median P/E of 50.9.

Is MEN a good buy?

This page is not buy or sell advice. MacroLens NP rates every NEPSE company on its fundamentals - MEN's rating, fair value, dump risk and broker activity are on the desk, free for 7 days.

Prices from NEPSE; figures from the company's quarterly reports; dividends, ownership and news from public filings. Research, not a recommendation to buy or sell - see the risk disclosure.